Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.
about
The aging kidney: increased susceptibility to nephrotoxicityGuidance cue netrin-1 and the regulation of inflammation in acute and chronic kidney diseaseCytokine and Chemokine Expression in Kidneys during Chronic Leptospirosis in Reservoir and Susceptible Animal ModelsThe regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injuryA nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusionExpression of chemokine receptors on peripheral blood T cells in children with chronic kidney disease.AMPK mediates the initiation of kidney disease induced by a high-fat dietReverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.Therapeutic Potential of Stem Cells from Human Exfoliated Deciduous Teeth in Models of Acute Kidney Injury.Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in miceLow-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.Global miRNA expression is temporally correlated with acute kidney injury in mice.Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone SynthesisAnalysis of the Relationship between Hypertrophy of the Ligamentum Flavum and Lumbar Segmental Motion with Aging Process.Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.Analysis of the Relationship between Ligamentum Flavum Thickening and Lumbar Segmental Instability, Disc Degeneration, and Facet Joint Osteoarthritis in Lumbar Spinal Stenosis.Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophyNew renal drug development to face chronic renal disease.Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis.Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms.Late intervention with the small molecule BB3 mitigates postischemic kidney injury.Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.Mammalian target of rapamycin complex 2 regulates inflammatory response to stress.Macrophage and epithelial cell H-ferritin expression regulates renal inflammation.Fas Ligand Has a Greater Impact than TNF-α on Apoptosis and Inflammation in Ischemic Acute Kidney InjuryMacrophage trafficking as key mediator of adenine-induced kidney injury.CX3CL1/CX3CR1 axis, as The Therapeutic Potential In Renal Diseases: Friend Or Foe?CCR2 contributes to the recruitment of monocytes and leads to kidney inflammation and fibrosis development.Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney.
P2860
Q26824198-905973BA-F699-41A3-A8EB-126DD574BA42Q26851850-A4A6C5B2-B8D4-4876-9968-EE59BA522FEDQ27345083-AC957D6D-5C4B-492D-95D2-5CDD2A0CC7B8Q33563134-193461D4-5B91-4333-9750-4AA872219A0FQ34674982-30A5BCBB-9836-493D-94F8-A0BA7E4BE4B1Q34935148-461717CD-36A9-4D67-A6BC-2746A078C31FQ35193649-D14CAD59-DD02-41BB-93D5-7781AAFCDFB8Q35238848-94EF6C49-8C7E-4145-BD9E-84022CD62A44Q35272259-643107B8-05EF-4818-931D-DBA0E672BBBBQ35657838-426BF771-53F7-4842-AD84-F54202A77B49Q35823993-7DFEF63F-93DD-40B8-AE03-FF95B1EBFC8EQ35923493-1B79027D-490E-4B8D-894F-0EBA11538918Q36129845-A86E58FC-7C5E-4659-9456-6B81268116EAQ36624687-D0BF96E2-249C-4125-BDBB-C18195D797B4Q36663328-1F203EC9-DF99-4CDE-BFA6-7F28EE925872Q36944645-20FF0170-6277-4EEE-B5B4-1DD51FC8B65EQ37030628-A6E942EB-4ADA-47D4-A0A4-2891C9A0CEF6Q37417240-10B9EE45-9329-4CCC-8048-C90AD5B2DE86Q37512112-7F7350DE-7D38-46AE-97F4-209EE69AE23EQ37524085-D28D74B7-9B8F-44F0-8372-9FBC6EB703D2Q38246640-4480D197-1188-46D9-970C-92D291EA87D4Q38282228-1E4093FF-B542-4FB8-BFF6-79FF8A50748FQ38985548-E65A82E6-3B58-43D1-8C23-A1FD36601337Q39716356-01194E49-8DF1-43BD-A66D-C824D0CB4C2CQ40998851-BF01B5BD-C165-457C-8C39-FF475C3A1143Q41201843-194F9A0D-FCF9-41D0-863F-6C41DB8F8744Q41468351-31E51FC8-E889-4E7F-AA5E-26C944832905Q41830820-0F6AC4D3-3B24-4224-A121-659201DDFED1Q41939544-54E66039-B573-4C46-B841-7CF0968E9451Q49985968-D8F06A29-2B05-43B2-966C-ADD416EFFC38Q50907659-23313273-55B2-41CB-825C-DCE542BBC97CQ53180854-AF79DEA2-B46F-48B6-B955-508CFF3AB3E7
P2860
Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@en
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@nl
type
label
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@en
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@nl
prefLabel
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@en
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@nl
P2093
P2860
P1476
Chemokine/chemokine receptor-m ...... ury to chronic kidney disease.
@en
P2093
Kengo Furuichi
Shuichi Kaneko
Takashi Wada
P2860
P2888
P356
10.1007/S10157-008-0119-5
P577
2008-12-16T00:00:00Z